JAB-8263

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameJAB-8263
Drug Alias NameJAB-8263
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsSolid tumoursPrimary MyelofibrosisArthritis, Rheumatoid +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJacobio Pharmaceuticals Group Co LtdJacobio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPrimary MyelofibrosisArthritis, Rheumatoid +[12] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A